drugset / Trial / NCT00204620
Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
Phase 2
Completed
28 enrolled
University Hospital Tuebingen
Arbeitsgemeinschaft fur Internistische Onkologie · collabGerman Sarcoma Group · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aims of this trial are to evaluate the efficacy of bendamustin in patients with metastatic soft tissue sarcoma who have progressed after or during an anthracycline-baesd chemotherapy and to assess the treatment of toxicity.
Timeline
- Start
- 2002-03
- Primary completion
- —
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bendamustin | Unknown | — | — |